Blog – 24x7 Pharma

13 Sep

Laronib 100mg: The Future of Tumor-Agnostic Cancer Treatment

13/09/2025
By Dipesh

Laronib 100mg is a branded formulation of Larotrectinib, a groundbreaking cancer medication known for its tumor-agnostic activity. It i...

12 Sep

Health

Ponaxen 45 mg: How Ponatinib Works for CML & Ph+ ALL Patients

12/09/2025
By Dipesh

Ponaxen 45mg is a formulation of Ponatinib, a powerful oral tyrosine kinase inhibitor (TKI) designed for the treatment of specific type...

11 Sep

Health

Selcaxen 40mg: Advanced Treatment for RET Altered Cancers

11/09/2025
By Dipesh

Selcaxen 40mg contains Selpercatinib, a targeted cancer therapy developed to treat certain types of cancers driven by RET (Rearranged d...

10 Sep

Health

Imaxen 400mg: A Game-Changer in Oncology

10/09/2025
By Dipesh

Imaxen 400mg, Imatinib Tablets Imaxen 400mg is a brand of Imatinib, a revolutionary anti-cancer medication that has transformed the tr...

09 Sep

Health

Capixet 500mg: Improving Patient Compliance in Cancer Care

09/09/2025
By Dipesh

Capixet 500mg, containing the active ingredient Capecitabine, is a chemotherapy medication primarily used in the treatment of various c...

08 Sep

Health

Tivoxen 1.34mg: Targeted Therapy for Advanced RCC

08/09/2025
By Dipesh

Tivoxen 1.34mg, Tivozanib Capsules Tivoxen 1.34mg is a pharmaceutical product containing the active ingredient Tivozanib, a potent and...

05 Sep

Health

Fineron 10mg: Advanced Therapy for Diabetic Kidney Disease

05/09/2025
By Dipesh

Finerenone, a new non-steroidal mineralocorticoid receptor antagonist (MRA), is an ingredient in the prescription drug Fineron 10mg. It...

04 Sep

Health

Selinex 20mg: A New Hope for Resistant Cancers

04/09/2025
By Dipesh

Selinexor, a new oral selective inhibitor of nuclear export (SINE), is the active ingredient in the prescription drug Selinex 20mg. It ...

03 Sep

Health

Acaluxen 100mg: Managing Chronic Leukemia and Lymphoma

03/09/2025
By Dipesh

Acalabrutinib (brand name Calquence) Acaluxen 100mg is a targeted therapy used in the treatment of specific types of blood cancers. It ...

02 Sep

Health

Moboxen 40mg (Mobocertinib): Targeted Therapy for EGFR Exon 20 NSCLC

02/09/2025
By Dipesh

Moboxen 40mg is a brand name for the drug Mobocertinib, an oral medication designed specifically to treat a rare subset of non-small ce...

01 Sep

Health

Alkixen 250mg: Improving Quality of Life for Cancer Patients

01/09/2025
By Dipesh

Crizotinib, marketed under the brand name Alkixen 250mg, is a targeted therapy medication primarily utilized in oncology for treating s...

30 Aug

Health

Ascimib (Asciminib): A Breakthrough in CML Treatment

30/08/2025
By Dipesh

Ascimib, containing the active ingredient asciminib, is a targeted therapy approved for the treatment of Philadelphia chromosome-positi...